Differential Acute and Long Term Actions of Succinic Acid Monomethyl Ester Exposure on Insulin-Secreting BRIN-BD11 Cells by Picton, Sally F. et al.
Int. Jnl. Experimental Diab. Res., Vol. 2, pp. 19-27
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 2001 OPA (Overseas Publishers Association) N.V.
Published by license under
the Harwood Academic Publishers imprint,
part of Gordon and Breach Publishing,
member of the Taylor & Francis Group.
Printed in the United States.
Differential Acute and Long Term Actions
of Succinic Acid Monomethyl Ester Exposure
on Insulin-Secreting BRIN-BD11 Cells
SALLY F. PICTON, PETER R. FLATT and NEVILLE H. McCLENAGHAN*
School ofBiomedical Sciences, University of Ulster, Coleraine, N Ireland, BT52 1SA, UK
(Received July 2000; In finalform October 2000)
Esters of succinic acid are potent insulin secreta-
gogues, and have been proposed as novel antidia-
betic agents for type 2 diabetes. This study
examines the effects of acute and chronic exposure
to succinic acid monomethyl ester (SAM) on insulin
secretion, glucose metabolism and pancreatic beta
cell function using the BRIN-BD11 cell line. SAM
stimulated insulin release in a dose-dependent
manner at both non-stimulatory (1.1mM) and stimu-
latory (16.7mM) glucose. The depolarizing actions
of arginine also stimulated a significant increase
in SAM-induced insulin release but 2-ketoiso-
caproic acid (KIC) inhibited SAM induced insulin
secretion indicating a possible competition between
the preferential oxidative metabolism of these two
agents. Prolonged (18hour) exposure to SAM re-
vealed decreases in the insulin-secretory responses
to glucose, KIC, glyceraldehyde and alanine.
Furthermore, SAM diminished the effects of non-
metabolized secretagogues arginine and 3-isobutyl-
1-methylxanthine (IBMX). While the ability of
BRIN-BD11 cells to oxidise glucose was unaffected
by SAM culture, glucose utilization was substan-
tially reduced. Collectively, these data suggest that
while SAM may enhance the secretory potential of
non-metabolized secretagogues, it may also serve as
a preferential metabolic fuel in preference to other
important physiological nutrients and compromise
pancreatic beta cell function following prolonged
exposure.
Keywords: Succinic acid monomethyl ester; Insulin secretion;
Glucose metabolism; Clonal pancreatic beta cells
Abbreviation: IBMX, 3-isobutyl-l-methylxanthine; KIC, 2-
ketoisocaproic acid; SAM, succinic acid monomethyl ester.
INTRODUCTION
Succinic acid serves as an important cellular
metabolic intermediate of glucose and man-
nose [11 and may act as a metabolic fuel through
its rapid mitochondrial metabolism. [2] However,
unlike glucose and other metabolizable nutrient
fuels such as the amino acids, [3-5] succinic acid
is not readily internalized into cells. [2,6] Addition
of ester moieties to molecules has long served as
an efficient means of internalizing compounds
that are not otherwise transported across the
plasma membrane. [7] Various esters of a diverse
range of nutrients and nutrient metabolites have
been demonstrated to exhibit enhanced biologi-
cal and insulinotropic activity over their parent
molecules.[8-14]
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Recent studies have demonstrated that vari-
ous esters of succinic acid are rapidly internal-
ized into pancreatic islets where they may evoke
insulin secretion through increasing the supply
of acetyl CoA and succinic acid to the Krebs
cycle.[7,15-18] Esters of succinic acid, serving as
potent insulin secretagogues, have therefore
been proposed to be potential novel antidiabetic
agents for the treatment of non-insulin-depend-
ent diabetes mellitus. [6,8] However, to date, the
apparent therapeutic potential of methyl esters
of succinic acid has largely been based on their
potent acute insulinotropic actions, with little
attention focused on their long term effects on
pancreatic beta cell function.
The present study examines both the acute
and chronic effects of succinic acid monomethyl
ester (SAM) on insulin secretion, glucose meta-
bolism and pancreatic beta cell function using
the clonal BRIN-BD11 cell line. The electrofu-
sion-derived BRIN-BD11 cell line, represents a
novel glucose-responsive insulin-secreting cell
line with intact functional features of the
parental pancreatic beta cell.[19-22] BRIN-BD11
cells have proven particularly useful for study-
ing the effects of acute and prolonged exposure
to a range of physiological and pharmacological
agents, including amino acids and antidiabetic
agents.[22-26] Through examining both the acute
and chronic effects of SAM, the present investi-
gation offers new insights into possible thera-
peutic application and the mechanisms by which
this novel insulinotropic antidiabetic agent regu-
lates pancreatic beta cell function.
MATERIALS AND METHODS
Chemicals
Reagents of analytical grade and deionized water
(Purite, Oxon, UK) were used throughout. Unless
otherwise stated, all chemicals were obtained
from Sigma Chemical Company Ltd (Poole,
Dorset, UK). RPMI 1640 tissue culture medium,
foetal calf serum (FCS), antibiotics (100U/ml
penicillin and 0.1mg/ml streptomycin), Hanks
balanced salt solution (HBSS) and trypsin/EDTA
(5.0g/1 trypsin (1:250) and 2.0g/1 EDTA in nor-
mal saline) were purchased from Gibco Life
Technolgies Ltd (Paisley, Strathclyde, UK).
Sodium dihydrogen orthophosphate and disodi-
um hydrogen orthosphosphate were obtained
from BDH (UK). Rat insulin standard was pur-
chased from Novo Industria (Copenhagen,
Denmark), while 125I-bovine insulin, D-[5-3H]glu
cose and D-[U-4C]glucose were from Amersham
International plc (Amersham, Bucks, UK).
Optiphase HiSafe scintillation fluid was pur-
chased from Wallac Scientific (UK).
Culture of Clonal Insulin-Secreting Cells
BRIN-BD11 cells were routinely maintained in
RPMI-1640 tissue culture medium supplement-
ed with 11.1mM glucose, 10%(v/v) foetal calf
serum, 100IU/ml penicillin and 0.1mg/ml
streptomycin in a 37C incubator with 5% CO2
and 95% air, as described previously. [19] The
BRIN-BD11 cells used for these studies were
from passages 28-35.
Acute Tests of Insulin Secretion
After seeding the cells at a density of 1.5 x 105
cells per well of 24-multiwell plates, BRIN-BD11
cells were left overnight at 37C to attach as
monolayers as described elsewhere.[9] BRIN-
BD11 cells were then cultured for 18 hours in the
presence or absence of 20mM SAM before per-
forming acute tests of insulin release. Prior to
testing, the RPMI-1640 culture medium was com-
pletely removed from each well and replaced
with lml Krebs-Ringer bicarbonate (KRB) buffer,
containing 115mM NaC1, 4.7mM KC1, 1.2mM
MgSO4, 1.28mM CaC12, 1.2mM KH2PO4, 25mM
Hepes and 8.4%(w/v) NaHCO3 (pH 7.4) supple-
mented with 0.5mg/ml bovine serum albumin
and 1.1mM glucose. Monolayers of cells were
then incubated for 40 minutes at 37C, after
which time the buffer was removed and replaced
with l ml KRB test buffer, supplemented with
glucose, succinic acid monomethyl ester, and
other test agents as detailed in the figures. After a
20min incubation (at 37C), the test buffer was
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removed from each of the wells and stored at
-20C for subsequent measurement of insulin by
radioimmunoassay as described previously. [27]
Determination of Cell Viability and Cellular
Insulin Content
Cell viability was determined by trypan blue
exclusion. [191 For measurement of cellular
insulin content, culture medium was removed
from the monolayers (1.5 x 105 cells per well)
and 500gl acid-ethanol (1.5% (v/v) 0.7tool/1
HC1, 75% (v/v) ethanol, 23.5% (v/v) H20 was
added. [19] After an overnight incubation at 4C,
cells were disrupted and acid-ethanol extracts
removed and stored at -20C for determination
of insulin. [27]
Glucose Metabolism
Glucose oxidation and utilization were assessed
after an 18h culture in the absence or presence
of 20mM SAM using methods described previ-
ously. [28,29] Briefly, BRIN-BD11 cells were har-
vested, and groups of 2 x 105 cells incubated
at 37C for 60 minutes at 1.1 or 16.7mM glucose
in 40gl of KRB buffer containing either l btCi of
D-[U-14C]glucose (glucose oxidation) or lgCi D-
[5-3H]glucose (glucose utilization). In the case of
glucose oxidation, the reaction was terminat-
edafter 60min by the addition of 50gl of
0.2M hydrochloric acid to the KRB buffer.
Phenylethylamine (100gl) was then added to the
filter paper placed on bottom of the vial for col-
lection of 14CO2 over a further 120 minute peri-
od (37C). For glucose utilization experiments,
the reaction was also terminated at 60min using
50gl 0.2M HC1, but in this case 500btl of H20
was added to the bottom of the vial to accumu-
late 3H20 aver a 15h period. Following addition
of 5ml of aqueous (HiSafe) scinitillation fluid
into the vial, 3H and 14C were measured using a
beta counter. Counts obtained were corrected by
means of a blank (processed as above but con-
taining no cells) and a standard (containing only
D-[U-14C] glucose or D-[5-BH] glucose).
Statistical Analyses
Results are presented as mean + SEM. Groups
of data were compared in each case using
unpaired Student’s t-test and two-way analysis
of variance in conjunction with Bonferroni’s
modified t-statistics. Differences were consid-
ered different if p <0.05.
RESULTS
Dose Responses to Succinic Acid
Monomethyl Ester
Succinic acid monomethyl ester (SAM) stimulat-
ed 1.5- and 2.5-fold increases (p<0.001) in
insulin secretion at 10 and 20mM respectively at
non-stimulatory (1.1mM) glucose (Fig. 1). In the
presence of a stimulatory (16.7mM) glucose,
10-20mM SAM similarly evoked a concentra-
tion-dependent 1.3-2.8-fold increase in insulin
release (p<0.001) confirming its action as a
potent insulin secretagogue in BRIN-BD11 cells
(Fig. 1). Concentrations of SAM less than 10mM
did not have an effect on insulin release (Fig. 1).
Raising the glucose concentration from 1.1 to
16.7mM, evoked an increase in insulin release in
the absence (2.2-fold, p<0.001) and presence
(1.9-2.5 fold, p<0.001) of each concentration of
SAM tested (Fig. 1).
Effects of SAM and Insulinotropic Actions
of Nutrients and 3-Isobutyl-l-Methylxanthine
As shown in Figure 2, 2-ketoisocaproic acid
(KIC) and glyceraldehyde stimulated respective
3.4-fold and 2.1-fold increases (p<0.001) in
insulin output at 16.7mM glucose, while the
amino acids alanine and arginine evoked 5.5 fold
and 2.6-fold increases (p<0.001), respectively.
The phosphodiesterase inhibitor 3-isobutyl-1-
methylxanthine (IBMX) also increased insuslin
release 7.7-fold (p<0.001) from BRIN-BD11 cells.
As shown in Figure 2, incubation with 20mM
SAM increased insulin output in the presence
of glyceraldehyde (1.3-fold increase, p<0.05)
and arginine (1.9-fold increase, p<0.001). SAM
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FIGURE 1 Effects of 0-20mM succinic acid monomethyl ester (SAM) on insulin secretion at non-stimulatory (1.1mM) and
stimulatory (16.7mM) glucose. Following 40min of preincubation with a buffer containing 1.1mM glucose, effects of SAM
were tested during a 20min incubation period. Values are mean + SEM for 6 separate observations. ***p<0.001 compared with
respective effects at 1.1mM glucose, aaap<0.001 compared with effects in the absence of SAM.
["1 16.7 mM glucose
16.7 mM glucose & 20 mM SAM
AAA
None KIC Gly Ala Arg IBMX
(20) (20) (20) (20) (1)
Addition (mM)
FIGURE 2 Effects of succinic acid monomethyl ester (SAM) on nutrient-induced insulin secretion. Following 40min of prein-
cubation with a buffer containing 1.1mM glucose, effects of 20raM SAM in the absence or presence of 2-ketoisocaproic acid
(KIC), D-glyceraldehyde (Gly), L-alanine (Ala), L-arginine (Arg) or 3-isobutyl-l-methylxanthine (IBMX) were tested during a
20min incubation period. Values are mean + SEM for 6 separate observations. *p<0.05, ***p<0.001 compared with respective
AA AAA effects at 16.7mM glucose in the absence of SAM. p<0.01, p<0.001 compared with effects at 16.7mM glucose in the
absence of addition.
(20mM) did not modify the stimulatory effects
of either alanine or IBMX, but reduced insulin
output induced by KIC by 65% (p<0.001) (Fig. 2).
Interestingly, alanine (p< 0.01), arginine (p<0.01)
and IBMX (p<0.001) each increased insulin
release over that of 16.7mM glucose and 20mM
SAM alone, while glyceraldehyde exerted no
influence and KIC decreased (p<0.001) insulin
output (Fig. 2).
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Effects of Preincubation with SAM
on Insulin Secretory Responsiveness
Preincubation of the monolyers with 20ram
SAM caused 1.4-fold increase in insulin release
at 16.7mM glucose (p<0.05) (Fig. 3). However,
preincubtion with SAM resulted in 52-54%
decrease (p<0.01-p<0.001) in KIC- and glycer-
Mdehyde-induced insulin output (Fig. 3). While,
SAM preincubation exerted no influence on
Manine-induced insulin secretion, it promoted
a 2.3-fold increase (p<0.001) nd 35% decrease
(p<0.05) in the effects of arginine nd IBMX,
respectively (Fig. 3). SAM preincubation
increased subsequent insulin output (2.1 fold,
p<0.001) at 1.1mM glucose (dt not shown).
While KIC and glyceraldehyde exerted no sig-
nificant effect on SAM-induced insulin secretion
t 16.7mM glucose following SAM preincub-
tion, alnine, rginine nd IBMX evoked
2.8-3.8-fold increases in insulin output (Fig. 3).
Effects of Prolonged Exposure to SAM
on BRIN-BD11 Cell Function
Prolonged (18hours) exposure to 20mM SAM
effectively removed the ability of BRIN-BD11
cells to respond to stimulatory glucose or any
other regulator tested (Fig. 4). SAM culture did
not alter basal insulin release (at 1.1mM glu-
cose) and insulin output in response to each sec-
retagogue was not significantly greater than
1.1mM glucose alone (data not shown). While
18h culture with 20mM SAM exerted no signifi-
cant effect on glucose oxidation (Fig. 5A), glu-
cose utilization at both 1.1mM and 16.7mM
glucose was significantly (p<0.001) decreased
(Fig. 5B). It is important to note that culture with
20mM SAM neither decreased the insulin con-
tent (74.8 + 3.2ng/106cells), nor the viability of
the BRIN-BD11 cells, suggesting that the detri-
mental effects on metabolism and beta cell func-
tion were not simply due to a decreased cell
number or reduced insulin content.
"E 20
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16.7 mM glucose (preincubation with SAM)
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FIGURE 3 Effects of preincubation with succinic acid monomethyl ester (SAM) on nutrient-induced insulin secretion.
Following 40min of preincubation with a buffer containing 1.1mM glucose in the absence or presence of 20mM SAM, effects of
2-ketoisocaproic acid (KIC), D-glyceraldehyde (Gly), L-alanine (Ala), L-arginine (Arg) or 3-isobutyl-l-methylxanthine (IBMX)
were tested at 16.7mM glucose during a 20min incubation period. Values are mean + SEM for 6 separate observations.
*p<0.05, **p<0.01, ***p<0.001 compared with respective effects at 16.7mM glucose (preincubation without SAM). aap<0.01,
aaap<0.001 compared with effects in the absence of addition.
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FIGURE 4 Effects of culture with succinic acid monomethyl ester (SAM) on nutrient-induced insulin secretion. After 18h cul-
ture in the absence or presence of 20mM SAM cells were preincubated for 40rain with a buffer containing 1.1mM glucose and
the effects of 2-ketoisocaproic acid (KIC), D-glyceraldehyde (Gly), L-alanine (Ala), L-arginine (Arg) or 3-isobutyl-l-methylxan-
thine (IBMX) were then tested at 16.7mM glucose during a 20min incubation period. Values are mean + SEM for 6 separate
observations. **p<0.01, ***p<0.001 compared with respective effects at 16.7mM glucose (culture without SAM). aaap<0.001
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FIGURE 5 Effects of culture with succinic acid monomethyl ester (SAM) on (A) glucose oxidation and (B) glucose utilization.
After 18h culture in the absence or presence of 20mM SAM, glucose oxidation and utilization were measured in the presence
of 1.1 or 16.7mM glucose. Values are mean + SEM for 4 separate observations. ***p<0.001 compared with respective effects at
M aaa .lm glucose, p<0.001 compared with effects after culture without SAM.
DISCUSSION
The present study examines the effects of acute
and chronic exposure to SAM on insulin secre-
tion, glucose metabolism and pancreatic beta cell
function. Unlike its parent molecule, succinic acid,
this ester is rapidly accumulated into pancreatic
beta cells where it acts as an effective insulin sec-
retagogue by virtue of its subsequent metab-
olism. [7,151 Consistent with previous studies on rat
pancreatic islets,[7,151 acute exposure to SAM
potently stimulated insulin secretion in a dose-
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related fashion from BRIN-BD11 cells at both non-
stimulatory (1.1mM) and stimulatory (16.7mM)
glucose concentrations. SAM was maximally
effective both as an initiator and potentiator of
insulin release at high concentrations (10-20mM),
as observed in normal islets. [7,15] The prominent
increase in insulin secretory potency of SAM at a
stimulatory as opposed to a non-stimulatory glu-
cose concentration, indicate that SAM can utilize
the metabolic and depolarizing actions of glucose
in its insulinotropic effects. In addition, the pre-
sent data also clearly indicate that BRIN-BD11
cells effectively transport SAM and utilize associ-
ated signal recognition pathways described in
normal pancreatic beta cells.[7,15-18,30]
In addition to the characteristic glucose-respon-
siveness of BRIN-BD11 cells, notable insulin-
secretory responses were also observed using a
range of other important nutrient secretagogues
and the phosphodiesterase inhibitor, IBMX.[3] As
with glucose, SAM effectively utilized the stimu-
latory actions of the glycolytic fuel, glyceralde-
hyde to enhance its insulinotropic activity.
Similarly, the depolarizing actions of arginine [21]
were also able to stimulate a significant increase
in SAM-induced insulin release. While, alanine
and IBMX showed no synergistic actions with
SAM, in the presence of KIC there was a signifi-
cant inhibition of insulin release. KIC is a potent
initiator of insulin secretion and is rapidly trans-
ported into beta cells [31,321 where it is readily
available as a metabolic fuel.[33-35] The inhibitory
effect of KIC on SAM-induced insulin release may
reflect some form of competition in the oxidative
metabolism of these two agents, which are imme-
diately and completely utilized.
Consistent with the view that SAM may inter-
fere with the metabolism of other secretagogues,
prior exposure to SAM (during a 40 minute
preincubation period) significantly decreased
the subsequent responsiveness to KIC and gly-
ceraldehyde. The secretory activity of IBMX was
also reduced, and the insulinotropic potential of
arginine, which does not serve as a significant
fuel for beta cell metabolism[5,21] was signifi-
cantly enhanced. Together these data suggest
that SAM may, like glucose, enhance the secret-
ory potential of non-metabolizable secreta-
gogues, [21,36,37] and serve as a preferential
metabolic fuel over that of other important
physiological nutrients.
Prolonging the exposure of BRIN-BD11 cells
to SAM to 18 hours had a detrimental effect on
subsequent responsiveness to each of the agents
tested. Indeed, in addition to abolishing secret-
ory responses to glucose, KIC, glyceraldehyde
and alanine, the effects of the potent non-metab-
olizable secretagogues arginine and IBMX were
also curtailed. These effects were not attribut-
able to a depletion of cellular insulin content
or to a reduction in BRIN-BD11 cell viability,
neither of which were affected by the culture
conditions. In addition to altering secretory
function, SAM-induced changes in the cellular
metabolism of glucose, the principal physiologi-
cal regulator of beta cell function.[31 While the
ability of the cells to oxidise glucose was un-
affected by chronic 18h exposure to SAM,
glucose utilization was substantially reduced in
response to SAM culture. This observation sug-
gests that cells retain the ability to metabolise
glucose but after prior exposure to SAM, BRIN-
BD11 cells are less likely to utilize glucose than
before, perhaps as a result of establishing a pre-
ference for SAM. The possibility of a different
anaplerotic function of succinic acid and KIC for
the regulation of mitochondrial metabolism in
these cells remains to be established.
Collectively these data reveal that SAM exerts
differential actions on the regulation of pancre-
atic beta cell function depending on the nature
and duration of exposure. The present study
highlights the fact that SAM may modulate the
insulinotropic actions of a number of agents
acting at different sites in the pancreatic beta
cell, suggesting the interaction or possible com-
mon signalling pathways used by SAM and
each of the agents tested. In considering SAM
as a potential antidiabetic agent for non-insulin-
dependent diabetes, attention should be
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focussed on possible deleterious actions and
potential reversibility of effects of long-term
exposure to SAM on pancreatic beta cell func-
tion. While previous observations indicate that
short-term exposure to SAM (120min) did not
affect either glucose oxidation or glucose utiliza-
tion, [7,15] the present in vitro study suggests that
more prolonged exposure may substantial-
ly alter insulin-secretory responsiveness. These
data merit substantiation by in vivo studies, but
similar desensitization of insulin-secretory func-
tion has been observed with sulphonylureas
both in vivo and in vitro during extended cul-
ture. [25,26,38,39] These findings clearly show the
need for further research bearing in mind that
SAM represents only one of an growing number
of insulinotropic nutrient esters[8,1-141 which
may prove to be better candidates for the future
therapy of type 2 diabetes.
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